The Ongoing Research on Bevacizumab in Non-Small Cell Lung Cancer
August 10th 2016Heather Wakelee, MD, associate professor of Medicine (Oncology), Stanford University Medical Center, discusses the evolving role of bevacizumab (Avastin) in the treatment of patients with non–small cell lung cancer.